Monday, October 3, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

LOS ANGELES - Edwards Lifesciences propped up its share price with false and misleading statements about its Sapien heart valve, and it fell from $82.81 to $64.60 in a day - 22 percent - when the truth came out, shareholders claim in Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...